TipRanks
Go Ultimate55% OFF

Guard Therapeutics International AB (DPHA) Financial Statements

Guard Therapeutics International AB Financial Overview

Guard Therapeutics International AB's market cap is currently $50.56M. The company's EPS TTM is $-4.07; its P/E ratio is -0.36; Guard Therapeutics International AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -15.00K$ -15.00K$ -15.00K
Operating Income$ -107.74M$ -99.91M$ -115.07M$ -114.92M$ -81.90M
EBITDA$ -107.74M$ -100.23M$ -114.91M$ -112.82M$ -82.01M
Net Income$ -108.85M$ -96.07M$ -113.32M$ -110.76M$ -82.16M
Balance Sheet
Cash & Short-Term Investments$ 49.83M$ 54.19M$ 83.74M$ 201.01M$ 188.60M
Total Assets$ 54.14M$ 55.74M$ 85.23M$ 202.60M$ 190.44M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -49.83M$ -54.19M$ -83.74M$ -201.01M$ -188.60M
Total Liabilities$ 13.51M$ 17.77M$ 18.49M$ 25.24M$ 14.66M
Stockholders' Equity$ 40.63M$ 37.97M$ 66.73M$ 177.36M$ 175.78M
Cash Flow
Free Cash Flow$ -109.35M$ -94.75M$ -116.05M$ -102.14M$ -77.59M
Operating Cash Flow$ -109.35M$ -94.75M$ -116.05M$ -102.14M$ -77.59M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -1.00K$ 0.00
Financing Cash Flow$ 107.22M$ 62.66M$ -779.00K$ 112.60M$ 176.30M

Currency in SEK

Guard Therapeutics International AB Earnings and Revenue History

-120M-80M-40M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Guard Therapeutics International AB Debt to Assets

080M160M240M0 %40 %80 %120 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets

Guard Therapeutics International AB Cash Flow

-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing

Guard Therapeutics International AB Forecast EPS vs Actual EPS